$BEAM
Beam Therapeutics Inc. Stock $beam

$beam Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000095017022015755 Filed on August 09, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$15.80M	$16.65M	$8.432M
YoY Change	1970.64%	277433.33%	140433.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$21.82M	$24.06M	$19.25M
YoY Change	38.3%	79.53%	87.41%
% of Gross Profit
Research & Development	$85.29M	$74.56M	$65.41M
YoY Change	56.14%	63.58%	-65.59%
% of Gross Profit
Depreciation & Amortization	$3.473M	$3.418M	$3.312M
YoY Change	107.34%	114.43%	136.91%
% of Gross Profit
Operating Expenses	$107.1M	$98.62M	$84.66M
YoY Change	52.14%	67.21%	-57.75%
Operating Profit	-$91.30M	-$81.97M	-$76.23M
YoY Change	31.12%	38.99%	-61.96%
Interest Expense	$10.51M	$10.14M	$6.559M
YoY Change	-66.0%	-161.29%	-845.34%
% of Operating Profit
Other Income/Expense, Net	$9.638M	$10.02M	$7.011M
YoY Change	-76.78%	-157.97%	-690.65%
Pretax Income	-$81.67M	-$71.95M	-$69.21M
YoY Change	190.44%	-5.64%	-65.66%
Income Tax	$2.410M	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$109.6M	-$71.95M	-$69.21M
YoY Change	289.7%	-5.64%	-65.66%
Net Earnings / Revenue	-693.56%	-432.08%	-820.85%
Basic Earnings Per Share	-$1.56	-$1.02	-$1.01
Diluted Earnings Per Share	-$1.56	-$1.02	-$1.01
COMMON SHARES
Basic Shares Outstanding	70.35M	70.21M	68.70M
Diluted Shares Outstanding	70.34M	70.21M	68.70M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.095B	$1.166B	$1.223B
YoY Change	17.26%	89.53%	142.82%
Cash & Equivalents	$156.5M	$265.6M	$296.8M
Short-Term Investments	$938.0M	$900.5M	$925.8M
Other Short-Term Assets	$14.36M	$13.78M	$16.88M
YoY Change	79.05%	8.35%	52.11%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.109B	$1.180B	$1.239B
YoY Change	17.79%	74.03%	140.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$111.2M	$106.1M	$94.29M
YoY Change	55.42%	64.88%	81.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.874M	$2.223M	$1.341M
YoY Change	78.31%	92.13%	-73.36%
Total Long-Term Assets	$241.3M	$238.5M	$213.9M
YoY Change	12.18%	10.88%	19.73%
TOTAL ASSETS
Total Short-Term Assets	$1.109B	$1.180B	$1.239B
Total Long-Term Assets	$241.3M	$238.5M	$213.9M
Total Assets	$1.350B	$1.418B	$1.453B
YoY Change	16.75%	58.82%	109.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.024M	$7.095M	$6.266M
YoY Change	-3.54%	-11.64%	-21.51%
Accrued Expenses	$48.42M	$46.73M	$66.55M
YoY Change	64.43%	102.53%	252.1%
Deferred Revenue	$159.9M	$139.7M	$115.0M
YoY Change	1147.09%	1293.32%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.210M	$2.389M	$2.337M
YoY Change	-1.25%	9.14%	11.29%
Total Short-Term Liabilities	$238.9M	$212.3M	$218.8M
YoY Change	135.58%	64.92%	114.33%
LONG-TERM LIABILITIES
Long-Term Debt	$1.388M	$1.787M	$2.404M
YoY Change	-61.42%	-57.21%	-48.85%
Other Long-Term Liabilities	$253.0K	$305.0K	$11.09M
YoY Change	-70.31%	-66.22%	726.38%
Total Long-Term Liabilities	$253.0K	$305.0K	$11.09M
YoY Change	-70.31%	-66.22%	726.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.9M	$212.3M	$218.8M
Total Long-Term Liabilities	$253.0K	$305.0K	$11.09M
Total Liabilities	$635.8M	$618.2M	$624.3M
YoY Change	110.01%	79.44%	130.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.000B	-$909.4M	-$837.5M
YoY Change	42.13%	34.65%	39.77%
Common Stock	$705.0K	$703.0K	$698.0K
YoY Change	4.14%	8.99%	13.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$714.5M	$800.2M	$829.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.350B	$1.418B	$1.453B
YoY Change	16.75%	58.82%	109.65%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$109.6M	-$71.95M	-$69.21M
YoY Change	289.7%	-5.64%	-65.66%
Depreciation, Depletion And Amortization	$3.473M	$3.418M	$3.312M
YoY Change	107.34%	114.43%	136.91%
Cash From Operating Activities	-$74.50M	-$52.28M	$218.5M
YoY Change	-2577.42%	60.73%	-666.36%
INVESTING ACTIVITIES
Capital Expenditures	-$11.79M	-$21.64M	$7.259M
YoY Change	103.93%	33.75%	-36.76%
Acquisitions
YoY Change
Other Investing Activities	-$24.39M	$20.38M	-$530.1M
YoY Change	-129.78%	568.48%	97.68%
Cash From Investing Activities	-$36.17M	-$1.262M	-$537.3M
YoY Change	-147.53%	-90.39%	92.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$54.00M
YoY Change			-79.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.562M	22.34M	55.68M
YoY Change	-99.51%	-86.08%	-78.02%
NET CHANGE
Cash From Operating Activities	-74.50M	-52.28M	218.5M
Cash From Investing Activities	-36.17M	-1.262M	-537.3M
Cash From Financing Activities	1.562M	22.34M	55.68M
Net Change In Cash	-109.1M	-31.20M	-263.2M
YoY Change	-127.28%	-127.18%	305.32%
FREE CASH FLOW
Cash From Operating Activities	-$74.50M	-$52.28M	$218.5M
Capital Expenditures	-$11.79M	-$21.64M	$7.259M
Free Cash Flow	-$62.71M	-$30.63M	$211.2M
YoY Change	-813.66%	87.43%	-521.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1412000
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q2	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#LicenseMember
	dei	Entity Central Index Key EntityCentralIndexKey	0001745999
	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#LicenseMember
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#LicenseMember
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q2	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#LicenseMember
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39208
	dei	Entity Registrant Name EntityRegistrantName	Beam Therapeutics Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-5238376
	dei	Entity Address Address Line1 EntityAddressAddressLine1	238 Main Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02142
	dei	City Area Code CityAreaCode	857
	dei	Local Phone Number LocalPhoneNumber	327-8775
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	BEAM
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70354594
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	265623000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	559994000
CY2022Q2	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Current AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiCurrent	900492000
CY2021Q4	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Current AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiCurrent	405653000
CY2021Q4	beam	Collaboration Receivable Current CollaborationReceivableCurrent	300000000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13775000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7360000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1179890000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1273007000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106090000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84258000
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	12746000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	12746000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117426000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	102718000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2223000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1724000
CY2022Q2	us-gaap	Assets Assets	1418375000
CY2021Q4	us-gaap	Assets Assets	1474453000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7095000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7474000
CY2022Q2	beam	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	35069000
CY2021Q4	beam	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	28921000
CY2022Q2	beam	Accrued Sub License Fees Current AccruedSubLicenseFeesCurrent	2147000
CY2021Q4	beam	Accrued Sub License Fees Current AccruedSubLicenseFeesCurrent	38743000
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16400000
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	42200000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	139666000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	86270000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9512000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7540000
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2389000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2287000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	212278000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	213435000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163985000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134810000
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1787000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3007000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	31035000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	31367000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	208824000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	262303000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	305000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2793000
CY2022Q2	us-gaap	Liabilities Liabilities	618214000
CY2021Q4	us-gaap	Liabilities Liabilities	647715000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70333989
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68581251
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70312114
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68389425
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	703000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	684000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1713086000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1594378000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4190000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-50000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-909438000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-768274000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	800161000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	826738000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1418375000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1474453000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16652000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25084000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	74556000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45577000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	139966000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	235683000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24062000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13403000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43309000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23676000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	98618000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	58980000
	us-gaap	Operating Expenses OperatingExpenses	183275000
	us-gaap	Operating Expenses OperatingExpenses	259359000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-81966000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-58974000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-158191000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-259347000
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	12200000
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-42300000
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	25800000
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-44200000
CY2022Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-4124000
CY2021Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	25814000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-11809000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	26852000
CY2022Q2	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	120000
CY2021Q2	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	741000
	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	-332000
	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	1046000
CY2022Q2	beam	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	2060000
CY2021Q2	beam	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-52000
	beam	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	2704000
	beam	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-72000
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10016000
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17279000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17027000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18466000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-71950000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-76253000
	us-gaap	Net Income Loss NetIncomeLoss	-141164000
	us-gaap	Net Income Loss NetIncomeLoss	-277813000
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1481000
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	55000
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4140000
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	40000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73431000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76198000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-145304000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-277773000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.54
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70210227
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70210227
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62210239
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62210239
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69461207
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69461207
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61215705
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61215705
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245561000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	252005000
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	120032000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4648000
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1758000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-15000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-201560000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	422429000
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	157785000
CY2021Q2	beam	Stock Issued During Period Value Success Payment Liability StockIssuedDuringPeriodValueSuccessPaymentLiability	30000000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10452000
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4083000
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	55000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-76253000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	548551000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	826738000
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1412000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	53936000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18035000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	820000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2659000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-69214000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	829068000
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22300000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21578000
	beam	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-25800000
	beam	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	44200000
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	646000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1481000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-71950000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	800161000
	us-gaap	Profit Loss ProfitLoss	-141164000
	us-gaap	Profit Loss ProfitLoss	-277813000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6730000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3067000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	1091000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	3000
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	154953000
	us-gaap	Share Based Compensation ShareBasedCompensation	39613000
	us-gaap	Share Based Compensation ShareBasedCompensation	15100000
	beam	Change In Operating Lease Right Of Use Assets ChangeInOperatingLeaseRightOfUseAssets	4094000
	beam	Change In Operating Lease Right Of Use Assets ChangeInOperatingLeaseRightOfUseAssets	4634000
	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	-332000
	beam	Change In Fair Value Of Contingent Consideration Liabilities ChangeInFairValueOfContingentConsiderationLiabilities	1046000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-11809000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	26852000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-63000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6957000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3106000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	197000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1150000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	382000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-29314000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1647000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	12345000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	11888000
	beam	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-300000000
	beam	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	50000000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-84000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	49988000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2488000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-102000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	166214000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71105000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28903000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27662000
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1020578000
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	428246000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	510880000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	162525000
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	620000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538601000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-292763000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	76365000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	418282000
	us-gaap	Interest Paid Net InterestPaidNet	214000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	109000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8479000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1118000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1046000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1466000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4955000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78016000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	413712000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-294371000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49844000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	572740000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177011000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278369000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226855000
	us-gaap	Interest Paid Net InterestPaidNet	307000
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8883000
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4430000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	35627000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	24164000
	beam	Fair Value Of Common Stock Issued To Settle Success Payment Liability FairValueOfCommonStockIssuedToSettleSuccessPaymentLiability	30000000
	beam	Equity Issuance Costs In Accounts Payable And Accrued Expenses EquityIssuanceCostsInAccountsPayableAndAccruedExpenses	25000
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	36513000
	beam	Fair Value Of Equity Instruments Issued In Connection With Asset Acquisition FairValueOfEquityInstrumentsIssuedInConnectionWithAssetAcquisition	120032000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-909400000
CY2022Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	1200000000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, incremental borrowing rate used in the calculation of lease liabilities, research and development expenses, stock-based compensation, contingent consideration liabilities, success payments and certain judgements regarding revenue recognition. Actual results could differ from these estimates.</span></p>
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	265623000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	212015000
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	12746000
CY2021Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14840000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278369000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226855000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	128842000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	100339000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22752000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16081000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106090000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84258000
CY2022Q2	us-gaap	Depreciation Depreciation	3418000
CY2021Q2	us-gaap	Depreciation Depreciation	1594000
	us-gaap	Depreciation Depreciation	6680000
	us-gaap	Depreciation Depreciation	2967000
CY2022Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-4124000
CY2021Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	25814000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-11809000
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	26852000
CY2022Q2	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Amortized Cost Basis AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAmortizedCostBasis	904682000
CY2022Q2	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Gain Before Taxes AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedGainBeforeTaxes	89000
CY2022Q2	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Loss Before Taxes AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedLossBeforeTaxes	4279000
CY2022Q2	beam	Available For Sale Debt Securities And Equity Securities Fv Ni AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNi	900492000
CY2021Q4	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Amortized Cost Basis AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAmortizedCostBasis	405703000
CY2021Q4	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Gain Before Taxes AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedGainBeforeTaxes	32000
CY2021Q4	beam	Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Loss Before Taxes AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedLossBeforeTaxes	82000
CY2021Q4	beam	Available For Sale Debt Securities And Equity Securities Fv Ni AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNi	405653000
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
CY2022Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
CY2021Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
	beam	Debt Securities Available For Sale Maturity Period DebtSecuritiesAvailableForSaleMaturityPeriod	less than one year
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8949000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11661000
CY2022Q2	beam	Accrued Research Costs AccruedResearchCosts	7762000
CY2021Q4	beam	Accrued Research Costs AccruedResearchCosts	3133000
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3754000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3330000
CY2022Q2	beam	Accrued Process Development And Manufacturing Costs AccruedProcessDevelopmentAndManufacturingCosts	4577000
CY2021Q4	beam	Accrued Process Development And Manufacturing Costs AccruedProcessDevelopmentAndManufacturingCosts	3833000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10027000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6964000
CY2022Q2	beam	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	35069000
CY2021Q4	beam	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	28921000
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	4469000
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	4563000
	us-gaap	Operating Lease Cost OperatingLeaseCost	8855000
	us-gaap	Operating Lease Cost OperatingLeaseCost	9103000
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	1531000
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	364000
	us-gaap	Variable Lease Cost VariableLeaseCost	2667000
	us-gaap	Variable Lease Cost VariableLeaseCost	574000
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	38000
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	360000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	270000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	378000
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	331000
	us-gaap	Sublease Income SubleaseIncome	662000
CY2022Q2	us-gaap	Lease Cost LeaseCost	5707000
CY2021Q2	us-gaap	Lease Cost LeaseCost	5287000
	us-gaap	Lease Cost LeaseCost	11130000
	us-gaap	Lease Cost LeaseCost	10055000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y1M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.074
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.070
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y3M18D
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	4945000
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	2310000
	us-gaap	Operating Lease Payments OperatingLeasePayments	9454000
	us-gaap	Operating Lease Payments OperatingLeasePayments	3995000
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30805000
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	798000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	35627000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	24164000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	9291000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22629000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23614000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24179000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21344000
CY2022Q2	beam	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	168733000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	269790000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	96293000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	173497000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6034192
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.40
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The holders of the Company’s common stock are entitled to one vote for each share of common stock.
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21578000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10452000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39613000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15100000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1755100
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	63.17
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	323948
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	76351
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	54.09
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7388993
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.71
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3005484
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	42.26
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9076381
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7225405
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-71950000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76253000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-141164000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-277813000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70210227
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70210227
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62210239
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62210239
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69461207
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69461207
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61215705
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61215705
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.54
	beam	Number Of Founder Shareholders NumberOfFounderShareholders	3

Files In Submission

Name	View Source	Status
0000950170-22-015755-index-headers.html	Edgar Link	pending
0000950170-22-015755-index.html	Edgar Link	pending
0000950170-22-015755.txt	Edgar Link	pending
0000950170-22-015755-xbrl.zip	Edgar Link	pending
beam-20220630.htm	Edgar Link	pending
beam-20220630.xsd	Edgar Link	pending
beam-ex31_1.htm	Edgar Link	pending
beam-ex31_2.htm	Edgar Link	pending
beam-ex32_1.htm	Edgar Link	pending
beam-ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
beam-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
beam-20220630_pre.xml	Edgar Link	unprocessable
beam-20220630_def.xml	Edgar Link	unprocessable
beam-20220630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
beam-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BEAM
Beam Therapeutics Inc. Stock $beam

2022 Q3 Form 10-Q Financial Statement

#000095017022015755 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BEAM Beam Therapeutics Inc. Stock $beam

2022 Q3 Form 10-Q Financial Statement

#000095017022015755 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BEAM
Beam Therapeutics Inc. Stock $beam